Calidi Biotherapeutics

Performance

About Calidi Biotherapeutics

Calidi Biotherapeutics is a biotechnology company focused on engineering genetic medicines for cancer, delivering targeted stem cell and viral therapies to sites of disease to activate the immune system against tumors. Their work spans oncology, including solid tumors and metastatic disease, with an emphasis on precise genetic approaches and innovative pipeline programs. The company operates primarily in the biotechnology and biopharmaceutical space, aiming to translate cutting-edge genetic medicine into therapies for cancer and other complex diseases. Headquartered in the United States, Calidi emphasizes advancing science through research and development across its science, pipeline, and clinical initiatives.